Featured articles from the journal CHEST®, January 2023

Published monthly, the journal CHESTopens in new tab/window^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The January issueopens in new tab/window of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activitiesopens in new tab/window, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“Starting in late 2022, readers have been earning continuing medical education (CME) credit for reading select journal CHEST articles and completing a posttest through the CHEST education portalopens in new tab/window,” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “The articles eligible for CME in January are, ‘Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPDopens in new tab/window,’ which is highlighted below, and ‘Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosisopens in new tab/window.’”

Also included in the current issue of the journal CHEST:

• ●

  COPD

A meta-analysis of 60 randomized clinical trials, “Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPDopens in new tab/window,” demonstrated a reduced all-cause mortality risk in patients treated with inhaled corticosteroids as part of their therapy regimen. A visual abstract for the research can be viewed hereopens in new tab/window.

• ●

  Critical Care

“Temporal Trends and Variation in Bronchoscopy Use for Acute Respiratory Failure in the United Statesopens in new tab/window” finds that the variable use of bronchoscopy among mechanically ventilated patients with respiratory failure suggests potentially unwarranted practice variation and need for further studies to clarify which patients may benefit from bronchoscopy. A visual abstract for the research can be viewed hereopens in new tab/window.

• ●

  Thoracic Oncology

A research letter, “A Biomarker-Based Approach for the Determination of Sample Adequacy During Endobronchial Ultrasound-Guided Transbronchial Needle Aspirationopens in new tab/window,” finds that a multivariate biomarker approach accurately reflects endobronchial ultrasound-guided transbronchial needle aspiration samples arising from predominantly lymphoid tissue and is suitable for subsequent diagnostic testing. A podcast of experts discussing the research can be found hereopens in new tab/window.

• ●

  Pulmonary Vascular

Original research, “Sex Differences in Outcomes of Percutaneous Pulmonary Artery Thrombectomy in Patients With Pulmonary Embolismopens in new tab/window,” finds that women had higher rates of in-hospital mortality, procedural bleeding, increased quantities of blood product transfusions and increased vascular complications. An editorial related to the research can be found hereopens in new tab/window.

---

Notes for editors

To view the entire January issue of CHEST journal (volume 163, issue 1), published by Elsevier, visit journal.chestnet.orgopens in new tab/window and follow @journal_CHESTopens in new tab/window on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at [email protected]opens in new tab/window.

About the journal CHEST^®

The journal CHESTopens in new tab/window, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.orgopens in new tab/window.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.opens in new tab/window

About Elsevier

As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.

Together with the Elsevier Foundationopens in new tab/window, we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELXopens in new tab/window, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.